InvestSMART

Immuron Limited (ASX: IMC) - Announcements

Current share price for IMC : $0.045 0.002 (4.65%)+

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Change in substantial holding GL 30 May 2019 11:58AM $0.130 $0.045 fallen by 65.38%
$15 Immuron Announces the Closing of Public Offering of ADSs 30 May 2019 10:52AM $0.130 $0.045 fallen by 65.38%
$15 Change of Director's Interest Notice PA 30 May 2019 9:24AM $0.145 $0.045 fallen by 68.97%
$15 Ceasing to be a substantial holder 30 May 2019 9:22AM $0.145 $0.045 fallen by 68.97%
$15 Appendix 3B and 708A Notice 30 May 2019 9:15AM $0.145 $0.045 fallen by 68.97%
$15 Ceasing to be a substantial holder 29 May 2019 3:00PM $0.140 $0.045 fallen by 67.86%
$15 Prospectus Supplement filed with SEC 27 May 2019 10:04AM $0.140 $0.045 fallen by 67.86%
$15 Form 6-K Underwriting Agreement filed with SEC 27 May 2019 10:02AM $0.140 $0.045 fallen by 67.86%
$15 Underwritten Public Offer 24 May 2019 6:21PM $0.190 $0.045 fallen by 76.32%
$15 Preliminary Prospectus Supplement filed with SEC 24 May 2019 12:21PM $0.190 $0.045 fallen by 76.32%
$15 Immuron Prices Underwritten Public Offering of ADSs 24 May 2019 10:49AM $0.190 $0.045 fallen by 76.32%
$15 Trading halt 24 May 2019 8:43AM $0.190 $0.045 fallen by 76.32%
$15 Proposed Public Offer of IMRN ADSs 24 May 2019 8:19AM $0.190 $0.045 fallen by 76.32%
$15 Immuron Corporate Presentation May 2019 17 May 2019 9:41AM $0.185 $0.045 fallen by 75.68%
$15 Becoming a substantial holder 8 May 2019 8:25AM $0.200 $0.045 fallen by 77.50%
$15 Immuron CEO to Present at the ThinkEquity Conference 29 Apr 2019 9:22AM $0.200 $0.045 fallen by 77.50%
$15 Appendix 3X - Initial Director's Interest Notice (GJ) 17 Apr 2019 12:05PM $0.220 $0.045 fallen by 79.55%
$15 Immuron Appoints CEO Dr. Gary S. Jacob to Board of Directors 17 Apr 2019 9:29AM $0.240 $0.045 fallen by 81.25%
$15 Immuron releases new corporate slide deck presentation 16 Apr 2019 10:11AM $0.230 $0.045 fallen by 80.43%
$15 Immuron sales surge by 66% in the Third Quarter of FY19 15 Apr 2019 8:40AM $0.210 $0.045 fallen by 78.57%
$15 Change in substantial holding 12 Apr 2019 10:42AM $0.225 $0.045 fallen by 80%
$15 Immuron Aims to Secure FDA Approval for IMM-124E 11 Apr 2019 9:27AM $0.195 $0.045 fallen by 76.92%
$15 Supplementary Form F-3 9 Apr 2019 11:11AM $0.180 $0.045 fallen by 75%
$15 Form F-3 2 Apr 2019 10:02AM $0.205 $0.045 fallen by 78.05%
$15 Company Update on CDI Clinical Trial and New Strategic Focus 19 Mar 2019 9:16AM $0.230 $0.045 fallen by 80.43%

451 - 475 of 782 results

Page 19 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.